|
1.
|
Goonatillake S, Khong R and Hoskin P:
Chemoradiation in gynaecological cancer. Clin Oncol (R Coll
Radiol). 21:566–572. 2009.
|
|
2.
|
Pearcey R, Brundage M, Drouin P, et al:
Phase III trial comparing radical radiotherapy with and without
cisplatin chemotherapy in patients with advanced squamous cell
cancer of the cervix. J Clin Oncol. 20:966–972. 2002.
|
|
3.
|
Tzioras S, Pavlidis N, Paraskevaidis E and
Ioannidis JP: Effects of different chemotherapy regimens on
survival for advanced cervical cancer: systematic review and
meta-analysis. Cancer Treat Rev. 33:24–38. 2007.
|
|
4.
|
Keys HM, Bundy BN, Stehman FB, et al:
Cisplatin, radiation, and adjuvant hysterectomy compared with
radiation and adjuvant hysterectomy for bulky stage IB cervical
carcinoma. N Engl J Med. 340:1154–1161. 1999.
|
|
5.
|
Morris M, Eifel PJ, Lu J, et al: Pelvic
radiation with concurrent chemotherapy compared with pelvic and
para-aortic radiation for high-risk cervical cancer. N Engl J Med.
340:1137–1143. 1999.
|
|
6.
|
Rose PG, Bundy BN, Watkins EB, et al:
Concurrent cisplatin-based radiotherapy and chemotherapy for
locally advanced cervical cancer. N Engl J Med. 340:1144–1153.
1999.
|
|
7.
|
Whitney CW, Sause W, Bundy BN, et al:
Randomized comparison of fluorouracil plus cisplatin versus
hydroxyurea as an adjunct to radiation therapy in stage IIB–IVA
carcinoma of the cervix with negative para-aortic lymph nodes: a
gynecologic oncology group and southwest oncology group study. J
Clin Oncol. 17:1339–1348. 1999.
|
|
8.
|
Peters WA III, Liu PY, Barrett RJ II, et
al: Concurrent chemotherapy and pelvic radiation therapy compared
with pelvic radiation therapy alone as adjuvant therapy after
radical surgery in high-risk early-stage cancer of the cervix. J
Clin Oncol. 18:1606–1613. 2000.
|
|
9.
|
Fukuda M, Shinkai T, Eguchi K, et al:
Phase II study of (glycolate-O,O′) diammineplatinum(II), a novel
platinum complex, in the treatment of non-small cell lung cancer.
Cancer Chemother Pharmacol. 26:393–396. 1990.
|
|
10.
|
Inuyama Y, Miyake H, Horiuchi M, Hayasaki
K, Komiyama S and Ota K: [A late phase II clinical study of
cis-diammine glycolato platinum, 254-S, for head and neck cancers].
Gan To Kagaku Ryoho. 19:871–877. 1992.
|
|
11.
|
Kato T, Nishimura H, Yakushiji M, et al:
[Phase II study of 254-S (cis-diammine glycolato platinum) for
gynecological cancer]. Gan To Kagaku Ryoho. 19:695–701. 1992.
|
|
12.
|
Uehara T, Watanabe H, Itoh F, et al:
Nephrotoxicity of a novel antineoplastic platinum complex,
nedaplatin: a comparative study with cisplatin in rats. Arch
Toxicol. 79:451–460. 2005.
|
|
13.
|
Kawai Y, Taniuchi S, Okahara S, Nakamura M
and Gemba M: Relationship between cisplatin or nedaplatin-induced
nephrotoxicity and renal accumulation. Biol Pharm Bull.
28:1385–1388. 2005.
|
|
14.
|
Kameyama Y, Okazaki N, Nakagawa M, Koshida
H, Nakamura M and Gemba M: Nephrotoxicity of a new platinum
compound, 254-S, evaluated with rat kidney cortical slices. Toxicol
Lett. 52:15–24. 1990.
|
|
15.
|
Sasaki Y, Amano T, Morita M, et al: Phase
I study and pharmacological analysis of
cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered
by 5-day continuous intravenous infusion. Cancer Res. 51:1472–1477.
1991.
|
|
16.
|
Nakamura Y, Hasegawa M, Hayakawa K, et al:
Induction of p53-dependent apoptosis in vivo by nedaplatin
and ionizing radiation. Oncol Rep. 7:261–265. 2000.
|
|
17.
|
Tanaka T, Yukawa K and Umesaki N:
Radiation reduces carboplatin sensitivity and enhances nedaplatin
sensitivity in cervical squamous cell carcinoma in vitro. Eur J
Gynaecol Oncol. 28:352–355. 2007.
|
|
18.
|
Hatae M, Takahashi T, Kodama S, et al: [A
dose escalation study of concurrent chemoradiation therapy with
nedaplatin for cervical cancer]. Gan To Kagaku Ryoho. 32:473–478.
2005.
|
|
19.
|
Ota K, Wakui A, Majima H, et al: [Phase I
study of a new platinum complex 254-S, cis-diammine
(glycolato)-platinum (II)]. Gan To Kagaku Ryoho. 19:855–861.
1992.
|
|
20.
|
Mabuchi S, Ugaki H, Isohashi F, et al:
Concurrent weekly nedaplatin, external beam radiotherapy and
high-dose-rate brachytherapy in patients with FIGO stage IIIb
cervical cancer: a comparison with a cohort treated by radiotherapy
alone. Gynecol Obstet Invest. 69:224–232. 2010.
|
|
21.
|
Yokoyama Y, Takano T, Nakahara K, et al: A
phase II multicenter trial of concurrent chemoradiotherapy with
weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku
Gynecologic Cancer Unit Study. Oncol Rep. 19:1551–1556. 2008.
|
|
22.
|
Niibe Y, Tsunoda S, Jobo T, et al: Phase
II study of radiation therapy combined with weekly nedaplatin in
locally advanced uterine cervical carcinoma (LAUCC): kitasato
gynecologic radiation oncology group (KGROG 0501)-initial analysis.
Eur J Gynaecol Oncol. 29:222–224. 2008.
|
